Status:
UNKNOWN
Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients
Lead Sponsor:
Peking University First Hospital
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
Brief Summary
This is a retrospective, observational, descriptive study which will include patients hospitalized for acute coronary syndrome (ACS) and treated with ticagrelor at discharge. Participants will come fr...
Detailed Description
Background： There are at least 2.5 million acute coronary syndromes (ACS) patients in China per year. Limited data about long term ticagrelor treatment patterns and clinical outcomes in Chinese ACS pa...
Eligibility Criteria
Inclusion
- ACS patients hospitalized during the following period: from January 2019 to September 2019
- Patients receiving ticagrelor as part of DAPT at hospital discharge.
- Patient enrolled into the follow-up program of ACS patients
Exclusion
- Patients participated in other interventional clinical trials
Key Trial Info
Start Date :
June 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 19 2021
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04861363
Start Date
June 19 2019
End Date
July 19 2021
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Peking University First Hospital
Beijing, China, 100034